Temporally resolved proteomics identifies nidogen-2 as a cotarget in pancreatic cancer that modulates fibrosis and therapy response
Temporal mass spectrometry proteomics, advanced microscopy, and in vivo modeling reveal nidogen-2 as a cotarget in PDAC.
Congratulations to @mbsanz.bsky.social MCR Paper of the Year 2024 Recipients, Brooke Pereira & Shona Ritchie, (co-led by @tcox.bsky.social ), for their latest work looking at the role of Nidogen-2 in pancreatic cancer published in Science Advances!
www.science.org/doi/10.1126/...
26.03.2025 22:20 β
π 8
π 4
π¬ 0
π 0
Targeting the NPY/NPY1R signaling axis in mutant p53βdependent pancreatic cancer impairs metastasis
Targeting NPY1R reduces mutant p53βdependent pancreatic cancer metastasis.
Excited to kick off my Bluesky posting by sharing this work by the lab looking at the role of neuropeptideY in #pancreaticcancer metastasis. An amazing piece of work and so thrilled to see it finally out!
@garvaninstitute.bsky.social
www.science.org/doi/10.1126/...
14.03.2025 00:47 β
π 6
π 1
π¬ 0
π 0